Hyophen is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Star Pharmaceuticals, Llc. The primary component is Methenamine; Benzoic Acid; Phenyl Salicylate; Methylene Blue; Hyoscyamine Sulfate.
| Product ID | 0076-0901_45640779-4ba0-45fd-e054-00144ff88e88 |
| NDC | 0076-0901 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Hyophen |
| Generic Name | Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2010-09-21 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Star Pharmaceuticals, LLC |
| Substance Name | METHENAMINE; BENZOIC ACID; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE |
| Active Ingredient Strength | 82 mg/1; mg/1; mg/1; mg/1; mg/1 |
| Pharm Classes | Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Oxidation-Reduction Activity [MoA],Oxidation-Reduction Agent [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2010-09-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-09-21 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| METHENAMINE | 81.6 mg/1 |
| SPL SET ID: | 2c1f0f4c-e57b-4df5-9a58-41d39c3d8893 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0076-0901 | Hyophen | Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 44523-741 | Hyophen | Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() HYOPHEN 85472508 4167986 Live/Registered |
BIOCOMP PHARMA, INC. 2011-11-15 |